Moyamoya Disease: A Cerebral Disorder of Children
キーワード:
Cerebral、 ischemia、 stroke、 collateral vasculature要旨
Moyamoya disease is an increasingly recognized arteriopathy associated with cerebral ischemia and has been associated with approximately 6% of childhood strokes. It is characterized by chronic progressive stenosis at the apices of the intracranial internal carotid arteries (ICA), including the proximal anterior cerebral arteries and middle cerebral arteries. Occurring in tandem with reduction in flow in the major vessels of the anterior circulation of the brain, there is compensatory development of collateral vasculature by small vessels near the carotid apices, on the cortical surface, leptomeninges, and branches of the external carotid artery supplying the dura and skull base. Moyamoya is an increasingly recognized entity associated with cerebral ischemia. Diagnosis is made from clinical and radiographic findings. Surgical revascularization is recommended for definitive treatment of children with moyamoya syndrome. Moyamoya is an increasingly recognized cause of stroke in both children and adults. Patients with certain conditions such as Down’s syndrome19 and sickle cell disease may be particularly at risk for moyamoya. Characteristic radiographic findings confirm the diagnosis, and recognition of the disease early in its course, with prompt institution of therapy, is critical in order to achieve the best outcome in patients. Revascularization surgery appears to be effective in preventing stroke in patients with moyamoya. Keywords: Cerebral, ischemia, stroke, collateral vasculature発行日
巻号
セクション
ライセンス
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |